Magellan Aerospace Corporation Announces Financial Results

TORONTO — Magellan Aerospace Corporation (“Magellan” or the “Corporation”) released its financial results for the second quarter of 2024. All amounts are expressed in Canadian dollars unless otherwise indicated. The results are summarized as fo

By: financialpost.com

Aug 06 2024
0
0 Views

TORONTO -- Magellan Aerospace Corporation (“Magellan” or the “Corporation”) released its financial results for the second quarter of 2024. All amounts are expressed in Canadian dollars unless otherwise indicated. The results are summarized as follows: Read More

B2Gold Reaches Agreement on Terms with Mali Government Relating to the Framework for the Fekola Complex; Approvals for Fekola Regional and Fekola Underground to be Expedited

Neuraptive Therapeutics Receives FDA Breakthrough Therapy Designation for NTX-001 and Provides Update on the Advancements of NTX-001 for the Treatment of Peripheral Nerve Injury Requiring Repair

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

Magellan Aerospace Corporation Announces Financial Results

Related

Boeing factory workers are voting whether to strike and shut down aircraft production

Europe at Peak LNG Heightens Risk of Stranded Assets, IEEFA Says

ECB to Cut Rates But Stay Guarded on Path Beyond: Decision Guide

Stock market today: Asian shares rally, encouraged by Wall Street storming back from an early slide

Oil Traders Confront a New World Without the China Bull Factor

Pan American Silver Reports Mineral Reserves and Mineral Resources as at June 30, 2024

Oil Steadies After Gain as Hurricane Francine Curtails Supply

Maxim Power Corp. Announces TSX Acceptance of Normal Course Issuer Bid

CI Financial Requests Morningstar DBRS to Withdraw Credit Ratings

Norfolk Southern fires CEO Alan Shaw for an inappropriate relationship with an employee

B2Gold Reaches Agreement on Terms with Mali Government Relating to the Framework for the Fekola Complex; Approvals for Fekola Regional and Fekola Underground to be Expedited

Neuraptive Therapeutics Receives FDA Breakthrough Therapy Designation for NTX-001 and Provides Update on the Advancements of NTX-001 for the Treatment of Peripheral Nerve Injury Requiring Repair

Boeing factory workers are voting whether to strike and shut down aircraft production